OSU James Cancer Hospital & Solove Research Institute  
 
Human Cancer Genetics Program
HomeAbout the ProgramResearchTraining OpportunitiesShared ResourcesFaculty & Staff
 
Home > Faculty & Staff > Faculty > Tatsuya Nakamura



Administration
Faculty
Michael A. Caligiuri
Carlo M. Croce
Samir Acharya
Dawn Allain
Doreen Agnese
Albert de la Chapelle
Michael A. Freitas
William E. Carson III
Harold A. Fisk
Richard Fishel
Joanna Groden
Denis C. Guttridge
Heather Hampel
Tim Hui-Ming Huang
Kay Huebner
Kimberly M. Kelly
Lawrence S. Kirschner
Gustavo Leone
Guido Marcucci
Rebecca S. Nagy
Tatsuya Nakamura
Michael Ostrowski
Jeffrey D. Parvin, MD, PhD
Robert Pilarski
Yuri Pekarsky
Danilo Perrotti
Matthew D. Ringel
Amanda E. Toland
Stephan M. Tanner
Kevin Sweet
Leigha Senter
David Symer
Amy Sturm
Christoph Schmutte
Michael B. Weinstein
Judith Westman
Post Doctoral Staff
Staff
For Faculty and Staff
Tatsuya Nakamura

Tatsuya Nakamura, Ph.D.
Assistant Professor

Department of Molecular Virology, Immunology and Medical Genetics

 

Biomedical Research Tower

460 W 12th Ave

Columbus, OH 43210

 

614/688-3215
 tatsuya.nakamura@osumc.edu

Research Interests:
My research is focused on ALL1/MLL and its oncogenic derivative, ALL1 fusion protein generated in an aggressive form of acute leukemias. Since ALL1 is an epigenetic regulator with the histone methyltranserase activity, the main work in my lab has been directed toward understanding how the alteration of epigenetic marks leads to human cancer. Additional epigenetic regulators including ASH1, ALR (MLL2), CLLD8, JMJD1C and JMJD1A are also currently investigated.

 Education & Training:
Jikei University Sch. of Med.   M.D.     1976    
Keio University Grad. Sch. of Medicine    Ph.D.    1984    

Recent Publications:

Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K, Alder H,
Nakamura T, Flomenberg N, Marcucci G, Calin GA, Kornblau SM, Kantarjian H, Bloomfield CD, Andreeff M, Croce CM. (2008) MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.  Blood 111:3183-3189.

Guenther MG, Lawton LN, Rozovskaia T, Frampton GM, Levine SS, Volkert T, Croce CM,
Nakamura T, Canaani E, Young RA. (2008) Epigenetic Lesions at Genes Encoding Stem Cell Developmental Regulators in Human Mixed-lineage Leukemia. Genes and Development in press.

Pichiorri F, Okumura H,
Nakamura T, Garrison P, Gasparini P, Suh S-S, Druck T, McCorkell KA, Barnes LD, Croce CM, Huebner K. (2008)  Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions. J Biol Chem in press.

Di Leva G, Gasparini P , Piovan C , Iorio M , Garofalo M , Cristian T, Ngankeu A,
Nakamura  T, Alder H , Nuovo G, Liu Y, Volinia S, Nephew K, Croce CM.  A regulatory "miRcircuitry" involving miR221&222 and ER
a determines ERa status of breast cancer cells. Submitted.

 

 

 

 

 




Arthur G. James Cancer Hospital and
Richard J. Solove Research Institute

1082 Biomedical Research Tower
460 West 12th Avenue
Columbus, OH 43210
Telephone: 614.292.3063
Contact Us
OSU James Cancer Hospital and Solove Research Institute